Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
15.64
+0.01 (0.06%)
At close: Feb 13, 2026

SHA:603739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
215.68248.73239.6213.87311.83249.92
Trading Asset Securities
223.1199.34292.05212.02170.4397.45
Cash & Short-Term Investments
438.78448.07531.64425.89482.27347.37
Cash Growth
-12.34%-15.72%24.83%-11.69%38.83%-2.69%
Accounts Receivable
424.76376.58330.26307.72254.31193.55
Other Receivables
40.1728.6825.8332.5136.321.81
Receivables
464.93405.26356.09347.91298.37220.55
Inventory
216.74188.95205.41173.63157.02124.73
Prepaid Expenses
-1.590.120.130.060.12
Other Current Assets
28.8425.3130.6821.8434.149.45
Total Current Assets
1,1491,0691,124969.4971.82742.22
Property, Plant & Equipment
1,5221,5601,5051,260843.51501.01
Long-Term Investments
94.5898.6480.8477.198.5916.14
Goodwill
84.284.284.220.2620.269.9
Other Intangible Assets
127.32131.13139.74135.63131.46122.25
Long-Term Deferred Tax Assets
22.4916.9918.0613.6412.038.91
Long-Term Deferred Charges
1.61.471.411.280.370.24
Other Long-Term Assets
40.3119.1480.57101.57233.7250.79
Total Assets
3,0422,9813,0342,5792,2221,451
Accounts Payable
204.13224.56231.95147.36112.1186.74
Accrued Expenses
32.99102.0991.7674.2672.8974.52
Short-Term Debt
608.52581.63568.97374.22135.9367.83
Current Portion of Long-Term Debt
62.3240.0392.88-1-
Current Income Taxes Payable
18.5810.068.4311.678.951.86
Current Unearned Revenue
16.2911.5110.677.4913.6212.43
Other Current Liabilities
120.5161.5783.5130.127.8329.42
Total Current Liabilities
1,0631,0311,088645.09372.33272.8
Long-Term Debt
13.8113.9662.0614999-
Long-Term Unearned Revenue
60.8463.9755.2647.9660.4555.66
Long-Term Deferred Tax Liabilities
2.341.463.022.722.881.24
Other Long-Term Liabilities
-0.150.150.171.526.52
Total Liabilities
1,1401,1111,209844.93536.18336.22
Common Stock
253.03253.03253.03252.44252.08154.67
Additional Paid-In Capital
702.9702.9712.08705.09693.84308.36
Retained Earnings
833.37796.9759.56704.12674.61578.05
Comprehensive Income & Other
-15.27-15.1-16.38-16.96-16.03-6.95
Total Common Equity
1,7741,7381,7081,6451,6051,034
Minority Interest
127.18132.3117.0989.2281.0781.12
Shareholders' Equity
1,9011,8701,8251,7341,6861,115
Total Liabilities & Equity
3,0422,9813,0342,5792,2221,451
Total Debt
684.65635.62723.92523.22235.9367.83
Net Cash (Debt)
-245.87-187.55-192.27-97.33246.34279.54
Net Cash Growth
-----11.88%-12.66%
Net Cash Per Share
-0.98-0.75-0.76-0.381.001.23
Filing Date Shares Outstanding
253.03253.03253.03252.62252.08216.53
Total Common Shares Outstanding
253.03253.03253.03252.44252.08216.53
Working Capital
85.9437.7535.77324.31599.5469.43
Book Value Per Share
7.016.876.756.526.364.78
Tangible Book Value
1,5631,5221,4841,4891,453901.98
Tangible Book Value Per Share
6.186.025.875.905.764.17
Buildings
-932.34931.6449.85398.83313.52
Machinery
-943.65929.21474.19443.58340.44
Construction In Progress
-203.8175.14704.43315.72122.58
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.